These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 21637899)
1. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. Kircik LH J Drugs Dermatol; 2011 Jun; 10(6):586-90. PubMed ID: 21637899 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel. Amar L; Kircik LH J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592 [TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. Hoffman LK; Del Rosso JQ; Kircik LH J Drugs Dermatol; 2017 Jun; 16(6):534-538. PubMed ID: 28686770 [TBL] [Abstract][Full Text] [Related]
4. Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color. Woolery-Lloyd HC; Keri J; Doig S J Drugs Dermatol; 2013 Apr; 12(4):434-7. PubMed ID: 23652891 [TBL] [Abstract][Full Text] [Related]
5. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. Thiboutot D J Drugs Dermatol; 2008 Jan; 7(1):13-6. PubMed ID: 18246693 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800 [TBL] [Abstract][Full Text] [Related]
7. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. Thielitz A; Lux A; Wiede A; Kropf S; Papakonstantinou E; Gollnick H J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):789-96. PubMed ID: 25399481 [TBL] [Abstract][Full Text] [Related]
8. Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population. Bhatia ND; Werschler WP; Cook-Bolden FE; Guenin E Cutis; 2020 Jul; 106(1):45-50;E1. PubMed ID: 32915939 [TBL] [Abstract][Full Text] [Related]
9. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319 [TBL] [Abstract][Full Text] [Related]
10. The evolution of azelaic acid. Fleischer AB Cutis; 2006 Feb; 77(2 Suppl):4-6. PubMed ID: 16566281 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Iraji F; Sadeghinia A; Shahmoradi Z; Siadat AH; Jooya A Indian J Dermatol Venereol Leprol; 2007; 73(2):94-6. PubMed ID: 17456913 [TBL] [Abstract][Full Text] [Related]
12. New approaches in dermatology: a clinical profile of azelaic acid. Lowe NJ Cutis; 1996 Jan; 57(1 Suppl):7. PubMed ID: 8654130 [No Abstract] [Full Text] [Related]
13. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne. Callender VD J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435 [TBL] [Abstract][Full Text] [Related]
14. Acne in patients with skin of color: practical management. Yin NC; McMichael AJ Am J Clin Dermatol; 2014 Feb; 15(1):7-16. PubMed ID: 24190453 [TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study. DuBois J; Ong GCW; Petkar G; Almeida LMC; Chavda R; Kerrouche N; Alexis AF J Drugs Dermatol; 2019 Jun; 18(5):514. PubMed ID: 31251543 [TBL] [Abstract][Full Text] [Related]
16. Combination azelaic acid therapy for acne vulgaris. Webster G J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S47-50. PubMed ID: 10898830 [TBL] [Abstract][Full Text] [Related]
17. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Grimes P; Callender V Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496 [TBL] [Abstract][Full Text] [Related]
18. Treating Acne in Patients With Skin of Color. Alexis AF; Harper JC; Stein Gold LF; Tan JKL Semin Cutan Med Surg; 2018 Jun; 37(3S):S71-S73. PubMed ID: 30192346 [TBL] [Abstract][Full Text] [Related]
19. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. Del Rosso JQ Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285 [TBL] [Abstract][Full Text] [Related]
20. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. El-Kashlan N; Cices A; Kaufman B; Da Rosa JC; Sanabria-Gonzalez I; Khattri S; Alexis A J Drugs Dermatol; 2024 Jun; 23(6):410-417. PubMed ID: 38834229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]